Depresszió: vizsgálatok itt: Lengyelország
22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Where
- Belchatow, Białystok, Bydgoszcz, Gdansk, Leszno, Poznan, Pruszkow, Tuszyn, Wroclaw
- Életkor
- 18 év to 65 év
- People
- 360 worldwide
- Run by
- Seaport Therapeutics
See details and how to joinNCT07065240 · EU 2025-521240-37-00 - 2. fázisCsak meghívásosAn Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
- Where
- Belchatow, Bialystok, Białystok, Bydgoszcz, Gdansk, Leszno, Poznan, Pruszkow, Tuszyn
- Életkor
- 18 év to 66 év
- People
- 360 worldwide
- Run by
- Seaport Therapeutics
See details and how to joinNCT07161700 · EU 2025-522347-18-00 - 2. fázisNot yet taking people in LengyelországA Study of Brenipatide in Participants With Major Depressive Disorder
- Where
- Bialystok, Bydgoszcz, Gdansk, Lodz, Lublin, Olkusz, Rybnik, Suchy Las, Warsaw
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07928245 · EU 2026-527689-65-00 - 3. fázisTaking peopleA research study to compare the antidepressant ability and safety of Samyr® tablets versus placebo tablets as an adjunct to additional antidepressant treatment in patients with major depressive disorder (MDD)
- Where
- Gdansk, Katowice, Poznan, Suchy Las
- Életkor
- 18 év and over
- People
- 868 worldwide
- Run by
- Mylan Inc.
See details and how to join2024-513019-29-00 · EU 2024-513019-29-00 - 3. fázisTaking peopleA Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Where
- Bialystok, Bielsko-Biala, Gdansk, Krakow, Poznan, Szczecin, Wroclaw, Zabrze
- Életkor
- 18 év to 75 év
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07412756 · EU 2025-522308-25-00 - 3. fázisTaking peoplePhase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Where
- Bydgoszcz, Gdansk, Gorlice, Grudziądz, Katowice, Leszno, Poznan, Warsaw
- Életkor
- 18 év to 74 év
- People
- 752 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06559306 · EU 2023-509070-36-00 - 3. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Where
- Bialystok, Bielsko-Biała, Bydgoszcz, Cracow, Gdansk, Leszno, Lodz, Olkusz, Poznań, Wroclaw, Zabrze
- Életkor
- 18 év to 75 év
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07775300 · EU 2025-522310-24-00 - 3. fázisTaking peopleA Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Where
- Bydgoszcz, Gdansk, Warsaw
- Életkor
- 18 év to 85 év
- People
- 330 worldwide
- Run by
- Cybin IRL Limited
See details and how to joinNCT06793397 · EU 2024-519270-40-00 - 3. fázisTaking peopleLong-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Belchatow, Białystok, Bia?ystok, Bydgoszcz, Gdansk, Grudziądz, Katowice, Torun, Warsaw
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00 - 3. fázisTaking peopleA Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Białystok, Bydgoszcz, Gdansk, Warsaw
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07196501 · EU 2025-520541-72-00 - 2. fázisTaking peopleA Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Where
- Gdansk, Katowice, Poznan
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Draig Therapeutics Ltd
See details and how to joinNCT07300969 - 3. fázisCsak meghívásosPhase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
- Where
- Bialystok, Bydgoszcz, Gdansk, Warsaw
- Életkor
- 18 év to 85 év
- People
- 468 worldwide
- Run by
- Cybin IRL Limited
See details and how to joinNCT06605105 · EU 2024-516805-22-00 - 3. fázisTaking peopleEvaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Where
- Białystok, Bia?ystok, Bydgoszcz, Gdansk, Katowice, Suchy Las, Torun, Tuszyn, Warsaw
- Életkor
- 18 év to 65 év
- People
- 500 worldwide
- Run by
- Vanda Pharmaceuticals
See details and how to joinNCT06830044 · EU 2024-520333-68-00 - 2. fázisTaking peopleDT-101 in Adults with Major Depressive Disorder
- Where
- Gdansk, Katowice, Poznan, Suchy Las
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- Draig Therapeutics Limited
See details and how to join2025-522784-15-00 · EU 2025-522784-15-00 - 4. fázisNot yet taking people in LengyelországEvaluation of the efficacy of Trazodone in improving emotional blunting symptoms in Patients with Major Depressive Disorder
- Where
- Gdansk, Katowice
- Életkor
- 18 év to 64 év
- People
- 120 worldwide
- Run by
- Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
See details and how to join2025-523267-38-00 · EU 2025-523267-38-00 - 4. fázisTaking peopleTDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
- Where
- Poznan
- Életkor
- 12 év and over
- People
- 180
- Run by
- Poznan University of Medical Sciences
See details and how to joinNCT07478796 - No phaseTaking peopleReal-world Clinical Response to Trazodone in Italy, Poland, and Romania
- Where
- Lodz
- Életkor
- 55 év and over
- People
- 120
- Run by
- Aziende Chimiche Riunite Angelini Francesco S.p.A
See details and how to joinNCT07377682 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Belchatow, Białystok, Bia?ystok, Gdansk, Grudziądz, Katowice, Torun
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06786624 · EU 2024-519418-29-00 - 3. fázisTaking peopleThe use of sildenafil in patients with univentricular heart after Fontan operation - a pilot SINFON-POL study.
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 60
- Run by
- National Institute Of Cardiology
See details and how to join2023-503913-31-01 · EU 2023-503913-31-01 - No phaseCsak meghívásosKetamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
- Where
- Gdansk
- Életkor
- 18 év to 90 év
- People
- 140
- Run by
- Medical University of Gdansk
See details and how to joinNCT05565352 - No phaseTaking peopleMultisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
- Where
- Krakow
- Életkor
- 18 év to 65 év
- People
- 90
- Run by
- Jakub Antczak
See details and how to joinNCT06363981 - No phaseTaking peopleEffect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
- Where
- Warsaw
- Életkor
- 18 év to 65 év
- People
- 90
- Run by
- Jakub Antczak
See details and how to joinNCT06371352